Skip to main content

Table 3 HPV genotypes in single, multiple, and mixed-HPV infections in cervix without SIL, with SIL and CC

From: TOP2A/MCM2, p16INK4a, and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions

 

O-Risk

NSIL

LSIL

HSIL

CC

 

n = 239

%

n = 901

%

n = 54

%

n = 291

%

HPV negative

 

74

30.9

1

0.1

0

0.0

5

1.7

Single HPV infection

 16

HR

40

16.7

119

13.2

7

13.0

123

42.3

 18

HR

4

1.7

13

1.4

3

5.6

23

7.9

 51

HR

6

2.5

19

2.1

1

1.8

0

0.0

 52

HR

2

0.8

19

2.1

0

0.0

4

1.4

 45

HR

1

0.4

7

0.8

1

1.8

13

4.5

 66

PHR

7

2.9

41

4.4

2

3.7

0

0.0

 53

PHR

9

3.8

23

2.5

1

1.8

0

0.0

 68

PHR

0

0.0

10

1.1

0

0.0

1

0.3

 26

PHR

0

0.0

2

0.2

0

0.0

1

0.3

 83

PHR

0

0.0

3

0.3

0

0.0

0

0.0

 6

LR

15

6.3

62

6.9

0

0.0

1

0.3

 70

LR

1

0.4

8

0.9

0

0.0

0

0.0

 11

LR

0

0.0

7

0.8

0

0.0

1

0.3

 54

LR

0

0.0

8

0.9

0

0.0

0

0.0

 44

LR

2

0.8

5

0.5

0

0.0

0

0.0

 74

UR

2

0.8

10

1.1

0

0.0

0

0.0

 62

UR

0

0.0

4

0.4

0

0.0

0

0.0

 69

UR

0

0.0

0

0.0

0

0.0

4

1.4

 89

UR

0

0.0

2

0.2

0

0.0

0

0.0

 67

UR

0

0.0

0

0.0

0

0.0

1

0.3

Multiple HPV infection

 16 and 52

HR

0

0.0

7

0.8

1

1.8

6

2.0

 31 and 33

HR

1

0.4

6

0.7

4

7.4

3

1.0

 16 and 18

HR

0

0.0

8

0.9

1

1.8

4

1.4

 16 and 56

HR

1

0.4

4

0.4

1

1.8

0

0.0

 16 and 39

HR

0

0.0

2

0.2

0

0.0

2

0.7

 53 and 66

PHR

1

0.4

6

0.7

0

0.0

0

0.0

 58 and 68

PHR

0

0.0

2

0.2

0

0.0

0

0.0

 66 and 53

PHR

0

0.0

2

0.2

0

0.0

0

0.0

 66 and 68

PHR

0

0.0

1

0.1

0

0.0

0

0.0

 11 and 54

LR

1

0.4

1

0.1

0

0.0

0

0.0

 6 and 11

LR

0

0.0

0

0.0

1

1.8

0

0.0

 6 and 54

LR

0

0.0

1

0.1

0

0.0

0

0.0

 6 and 7

LR

0

0.0

1

0.1

0

0.0

0

0.0

 6 and 70

LR

0

0.0

1

0.1

0

0.0

0

0.0

 69 and 71

UR

1

0.4

3

0.3

1

1.8

0

0.0

Mixed HPV infection

 16 and 6

HR, LR

4

1.7

20

2.2

1

1.8

3

1.0

 53 and 6

PHR, LR

0

0.0

8

0.9

0

0.0

0

0.0

 16 and 53

HR, PHR

1

0.4

6

0.7

0

0.0

0

0.0

 66 and 6

PHR, LR

0

0.0

6

0.7

0

0.0

1

0.3

 39 and 6

HR, LR

0

0.0

4

0.4

0

0.0

2

0.7

 68 and 6

PHR, LR

1

0.4

5

0.5

0

0.0

0

0.0

 16 and 68

HR, PHR

0

0.0

5

0.5

0

0.0

0

0.0

 16 and 66

HR, PHR

0

0.0

4

0.4

0

0.0

0

0.0

 18 and 6

HR, LR

0

0.0

3

0.3

0

0.0

1

0.3

  1. O-Risk Oncogenic risk, NSIL Non-squamous intraepithelial lesions, LSIL Low-grade squamous intraepithelial lesions, HSIL High-grade squamous intraepithelial lesions, CC Cervical cancer, HR High risk, PHR Probably high risk, LR Low risk, UR Indeterminate risk. Single HPV Infection with one genotype (shown are the five most prevalent genotypes by risk group), Multiple HPV Infection with two genotypes of the same risk group (shown are the most prevalent genotypes by risk group), Mixed HPV Infection with genotypes of different risk groups (shown are the most prevalent combinations)